Zdrowie i gospodarka · 16/03/2023

FDA Releases Final Guidance on Definitions of Suspect and Illegitimate Products Under DSCSA

The US Food and Drug Administration (FDA) has released a final guidance to clarify the definitions of 'suspect' and 'illegitimate' products under the Drug Supply Chain Security Act (DSCSA). The guidance aims to help the pharmaceutical industry better understand key terms such as counterfeit, diverted, stolen, and fraudulent transactions.